Janux Therapeutics, Inc. upgraded to Strong Buy: below cash value, strong runway, TRACTr progress, Merck/BMY milestones.

In this Eye on Patents column, IP expert Jason Lye explains how China became the global leader in chemistry patents ...

An explanation of real-world asset (RWA) tokenization use cases and guidance on the tokenization process, including asset ...

Discover how the Sales Comparison Approach helps appraise properties by evaluating similar recent sales in real estate, ...

Value investing is built on a simple idea: markets don’t always price companies accurately, and patient investors can take ...

The private credit market, which has grown rapidly in recent years, has increasingly come under the spotlight. Rarely a day ...

The biotechnology sector is evolving from a model centered on long-term R&D investment into one where scientific advancement can be reflected as measurable financial value. As drug candidates advance ...

Keyrock, a Brussels-based digital asset services firm, has raised a Series C round led by SC Ventures, the venture arm of Standard Chartered, at a valuation of $1.1 billion, the company said in a ...

At the advent of the new year, many Americans decide to make positive changes in their lives, focusing on individual or family-related factors. Similarly, active community members take stock of their ...

As people build savings over time, their financial priorities often change. What begins as a focus on saving and investing can gradually shift toward planning how those assets will be managed and ...

Regulators issue long-awaited guidance that is a stark reversal from the previous administration’s approach to regulating digital assets. Most crypto assets, be they currencies, collectibles, ...